| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/30/2001 | US6180143 Sugar-free; storage stability |
| 01/30/2001 | US6180141 Composite gel microparticles as active principle carriers |
| 01/30/2001 | US6180140 Modified amino acids for drug delivery |
| 01/30/2001 | US6180138 Suspending lipid-regulating agent with surfactant solution in presence or absence of electrolyte; drying; granulating mixture in presence excipients; forming finished dosage form |
| 01/30/2001 | US6180137 Etherlipid-containing multiple lipid liposomes |
| 01/30/2001 | US6180136 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
| 01/30/2001 | US6180134 For treating subject with small effector molecules which are normally subject to rapid renal clearance from bloodstream; for treating septic shock, for use in treating inflammation related to neutrophil recruitment and tissue infiltration |
| 01/30/2001 | US6180133 Antioxidant composition for topical/transdermal prevention and treatment of wrinkles |
| 01/30/2001 | US6180129 Protecting a fluid sensitive biological agent in the device from fluid; for delivering beneficial fulids such as hormones to animals |
| 01/30/2001 | US6180116 Histidine derivatives, preparation process and uses |
| 01/30/2001 | US6180114 Therapeutic delivery using compounds self-assembled into high axial ratio microstructures |
| 01/30/2001 | US6180099 Method of using immunoglobulin and fiber-containing compositions for human health |
| 01/30/2001 | US6180096 Formulations for protection of peg-interferon alpha conjugates |
| 01/30/2001 | US6180093 As lubricant for contact lenses or dry eye |
| 01/30/2001 | US6179871 Means for cartilage repair |
| 01/30/2001 | US6179826 Implantable therapy systems and methods |
| 01/30/2001 | CA2148112C New pharmaeutical dosage form for transdermal administration |
| 01/30/2001 | CA2011637C Compositions for the sustained-release of chlorhexidine |
| 01/30/2001 | CA2011171C Biodegradable poly (phosphate esters) |
| 01/29/2001 | CA2280925A1 Stabilized cefuroxime axetil |
| 01/26/2001 | CA2314418A1 Incorporation of cholesterol lowering agents into confectionery dosage forms |
| 01/25/2001 | WO2001005954A1 Antisense modulation of liver glycogen phosphorylase expression |
| 01/25/2001 | WO2001005944A1 Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
| 01/25/2001 | WO2001005873A1 Neutral lipopolymer and liposomal compositions containing same |
| 01/25/2001 | WO2001005802A1 Antisense modulation of fadd expression |
| 01/25/2001 | WO2001005797A1 Titanium derived compounds, preparation and use thereof |
| 01/25/2001 | WO2001005731A1 Method for immobilising physiologically active compounds |
| 01/25/2001 | WO2001005586A1 Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery |
| 01/25/2001 | WO2001005481A2 Method and apparatus for the recovery of non-solvent type fills from gelatin capsules |
| 01/25/2001 | WO2001005431A1 Taste masking of oral quinolone liquid preparations using ion exchange resins |
| 01/25/2001 | WO2001005430A1 Sustained release drug dispersion delivery device |
| 01/25/2001 | WO2001005429A2 Powder particles with smooth surface for use in inhalation therapy |
| 01/25/2001 | WO2001005413A1 Use of propionic bacteria for producing propionic acid and/or propionates in the colon |
| 01/25/2001 | WO2001005411A1 Compositions addressing inflammation and/or degenerative disorders |
| 01/25/2001 | WO2001005409A1 Novel spinal and epidural anaesthetic |
| 01/25/2001 | WO2001005407A1 Rapid immediate release oral dosage form |
| 01/25/2001 | WO2001005406A1 Glycyrrhizin preparations for transmucosal absorption |
| 01/25/2001 | WO2001005397A1 Procyanidin oligomers inhibiting matrix metalloproteinases and medicine having effective composition of the same |
| 01/25/2001 | WO2001005388A2 Use of a fatty derivative for the treatment of external secretiondisorders |
| 01/25/2001 | WO2001005381A1 Percutaneously absorbable preparations |
| 01/25/2001 | WO2001005380A1 Sustained release compositions, process for producing the same and use thereof |
| 01/25/2001 | WO2001005379A1 BIODEGRADABLE POLY(ALKYLENE OXIDE)-POLY(p-DIOXANONE) BLOCK COPOLYMER SOLUBLE IN ORGANIC SOLVENTS, AND DRUG DELIVERY COMPOSITION COMPRISING SAME |
| 01/25/2001 | WO2001005378A1 Ambroxol-containing lozenge |
| 01/25/2001 | WO2001005377A1 Method for inactivating bacteria associated with bacterial vaginosis using cellulose acetate phthalate and/or hydroxypropyl methylcellulose phthalate |
| 01/25/2001 | WO2001005375A1 Vinyl ether lipids with cleavable hydrophilic headgroups |
| 01/25/2001 | WO2001005374A1 Methods for preparation of lipid-encapsulated therapeutic agents |
| 01/25/2001 | WO2001005373A1 Methods and apparatus for preparation of lipid vesicles |
| 01/25/2001 | WO2001005372A2 A liposome composition having resistance to freeze/thaw damage |
| 01/25/2001 | WO2001005371A1 Method for modifying physical and chemical and/or biological properties of a material |
| 01/25/2001 | WO2001005370A1 Antiadhesion barriers containing water-soluble alginate and carboxymethyl cellulose as major components and preparation method thereof |
| 01/25/2001 | WO2001005368A1 Use of at least one extract of a plant of the genus lannea in a cosmetic or dermopharmaceutical composition |
| 01/25/2001 | WO2001005362A2 Emulsifier-free finely dispersed water-in-oil-type systems |
| 01/25/2001 | WO2001005361A2 Emulsifier-free finely dispersed systems of the oil-in-water type |
| 01/25/2001 | WO2001005355A2 Formulations for il-11 |
| 01/25/2001 | WO2001005352A1 Apparatus and method for administration of medication |
| 01/25/2001 | WO2001005232A1 Stable biocidal compositions |
| 01/25/2001 | WO2000072827A3 Porous drug matrices and methods of manufacture thereof |
| 01/25/2001 | WO2000071095A3 Release of poorly soluble agents |
| 01/25/2001 | WO2000066183A8 Vascular embolic materials having multifunctions |
| 01/25/2001 | WO2000065030A3 Microencapsulated genetically engineered e. coli dh 5 cells for the removal of undesired electrolytes and/or metabolites |
| 01/25/2001 | WO2000061174A3 Use of pegylated interferon alpha for renal cell carcinoma treatment |
| 01/25/2001 | WO2000056356A3 Induction of antigen-specific unresponsiveness by glioblastoma culture supernatants (gcs) |
| 01/25/2001 | WO2000056297A3 Pharmaceutical compositions comprising dipeptidy peptidase iv inhibitors for the promotion of growth |
| 01/25/2001 | WO2000056296A3 Compositions for improving fertility |
| 01/25/2001 | DE19934610A1 Rapid-release extrudates containing low viscosity hydroxypropylcellulose, useful for formulating plant protecting agents and oral pharmaceutical and veterinary compositions |
| 01/25/2001 | DE19934523A1 Transdermalsysteme zur Abgabe von Muscarin-Rezeptor-Antagonisten und ihre Verwendung zur Behandlung von Spasmen der glatten Muskulatur im urologischen Bereich Transdermal systems for the delivery of muscarinic receptor antagonists and their use for treating spasm of smooth muscle in the urological field |
| 01/25/2001 | DE19933705A1 New anaesthetic for epidural administration comprises liposomes containing a lipophilic gas, especially xenon |
| 01/25/2001 | DE19933148A1 Ambroxolhaltige Lutschtablette Ambroxol lozenge |
| 01/25/2001 | DE19932603A1 Wirkstoffhaltiger Mehrschichtfilm aus in situ vernetzten hydrophilen Polymeren Medicated multilayer film composed of crosslinked hydrophilic polymers in situ |
| 01/25/2001 | CA2379683A1 Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
| 01/25/2001 | CA2379489A1 Procyanidin oligomers inhibiting matrix metalloproteinases and medicine having effective composition of the same |
| 01/25/2001 | CA2379366A1 A liposome composition having resistance to freeze/thaw damage |
| 01/25/2001 | CA2379354A1 Formulations for il-115 |
| 01/25/2001 | CA2379313A1 Glycyrrhizin preparations for transmucosal absorption |
| 01/25/2001 | CA2379060A1 Neutral lipopolymer and liposomal compositions containing same |
| 01/25/2001 | CA2378829A1 Sustained release drug dispersion delivery device |
| 01/25/2001 | CA2378714A1 Sustained release compositions, methods for producing the same and uses thereof |
| 01/25/2001 | CA2378430A1 Methods and apparatus for preparation of lipid vesicles |
| 01/25/2001 | CA2378336A1 Rapid immediate release oral dosage form |
| 01/24/2001 | EP1070741A1 Coprocessed polysaccharide product with crosslinked polyvinylpyrrolidone |
| 01/24/2001 | EP1070740A1 Coprocessed polysaccharide product with insoluble carboxymethylcellulose |
| 01/24/2001 | EP1070725A1 Solid dispersion containing sialic acid derivative |
| 01/24/2001 | EP1070504A1 Materials for preventing arteriosclerosis, immunopotentiating materials, vertebrates fed with these materials and eggs thereof |
| 01/24/2001 | EP1070502A2 Compositions and methods for treating or preventing inflammatory diseases |
| 01/24/2001 | EP1070501A1 Method of preparing a dispersible fluoxetine tablet |
| 01/24/2001 | EP1069919A2 Stimulus sensitive gel with radioisotope and methods of making |
| 01/24/2001 | EP1069914A1 Controlled release tablet produced from linear water-insoluble polysaccharides |
| 01/24/2001 | EP1069913A1 Gelling ophthalmic compositions containing xanthan gum |
| 01/24/2001 | EP1069912A1 Injectable igf-formulations containing succinate as buffering agent |
| 01/24/2001 | EP1069902A1 Use of phospholipids for the manufacture of a medicament for the prevention of adhesions |
| 01/24/2001 | EP1069896A1 Carvedilol-galenics |
| 01/24/2001 | EP1069892A1 Therapeutic system which can be moisture-activated |
| 01/24/2001 | EP1069891A1 Wettable microcapsules having ethylcellulose coated cores |
| 01/24/2001 | EP1069890A1 Incorporation of active substances in carrier matrixes |
| 01/24/2001 | EP1069889A1 Partikulärer wirkstoffträger für die pulmonale applikation |
| 01/24/2001 | EP1069888A1 Use of particulate contrast agents in diagnostic imaging for studying physiological parameters |
| 01/24/2001 | EP1069887A1 Aerosol composition |
| 01/24/2001 | EP1069886A1 Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance |
| 01/24/2001 | EP1069885A1 Ophthalmic solution comprising glycogen |
| 01/24/2001 | EP1069883A1 Cholesterol sulfate compositions for enhancement of stratum corneum function |